192 related articles for article (PubMed ID: 37833849)
1. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Souza M; Diaz I; Barchetta I; Mantovani A
Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
[TBL] [Abstract][Full Text] [Related]
2. Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers.
McHenry S; Zong X; Shi M; Fritz CDL; Pedersen KS; Peterson LR; Lee JK; Fields RC; Davidson NO; Cao Y
Hepatol Commun; 2022 Dec; 6(12):3299-3310. PubMed ID: 36221229
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
Mantovani A; Petracca G; Beatrice G; Csermely A; Tilg H; Byrne CD; Targher G
Gut; 2022 Apr; 71(4):778-788. PubMed ID: 33685968
[TBL] [Abstract][Full Text] [Related]
5. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
6. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
[TBL] [Abstract][Full Text] [Related]
7. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
[TBL] [Abstract][Full Text] [Related]
8. High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Chen W; Wang M; Jing X; Wu C; Zeng Y; Peng J; Cai X
J Gastroenterol Hepatol; 2020 Dec; 35(12):2051-2065. PubMed ID: 32579269
[TBL] [Abstract][Full Text] [Related]
9. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Ha J; Yim SY; Karagozian R
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2496-2507.e5. PubMed ID: 36442727
[TBL] [Abstract][Full Text] [Related]
10. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
[TBL] [Abstract][Full Text] [Related]
11. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.
Liu SS; Ma XF; Zhao J; Du SX; Zhang J; Dong MZ; Xin YN
Lipids Health Dis; 2020 May; 19(1):118. PubMed ID: 32475354
[TBL] [Abstract][Full Text] [Related]
12. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
13. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
[TBL] [Abstract][Full Text] [Related]
14. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
[TBL] [Abstract][Full Text] [Related]
16. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
17. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
18. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
[TBL] [Abstract][Full Text] [Related]
20. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
Jagirdhar GSK; Qasba RK; Pattnaik H; Rama K; Banga A; Reddy ST; Flumignan Bucharles AC; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
World J Gastroenterol; 2023 Jun; 29(21):3362-3378. PubMed ID: 37377589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
